24
Participants
Start Date
January 31, 2005
Primary Completion Date
August 31, 2008
Study Completion Date
January 31, 2009
infliximab
5 mg/kg IV at baseline, 2 weeks, 6 weeks and then every 8 weeks x 6
placebo
placebo IV at baseline, 2 weeks, 6 weeks and then every 8 weeks x 6
University of Pittsburgh, Pittsburgh
Collaborators (1)
Centocor, Inc.
INDUSTRY
University of Pittsburgh
OTHER